Amgen Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Other-Non-Cash-Items" stands at -0.935 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025.
Amgen Inc's third quarter result of -1.95 Billion USD for the item "Other Non Cash Items" represents a decrease of -382.85 percent compared to it's second quarter result.
Also, Amgen Inc's third quarter result of -1.95 Billion USD for the item "Other Non Cash Items" represents a decrease of -26.61 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Amgen Inc's third quarter result of -0.935 Billion USD for the item "Other Non Cash Items" represents a decrease of -77.76 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.353 Billion United States Dollars compared to the value the year prior.
The 1 year change is 0.353 Billion United States Dollars.
The 3 year change is -2.03 Billion United States Dollars.
The 5 year change is -0.85 Billion United States Dollars.
The 10 year change is -0.858 Billion United States Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Other Non Cash Items | 905,699,262,464.00 |
![]() | Johnson & Johnson - Other Non Cash Items | 486,508,953,600.00 |
![]() | AbbVie Inc - Other Non Cash Items | 399,570,305,024.00 |
![]() | Roche Holding AG - Other Non Cash Items | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Other Non Cash Items | 280,205,508,085.11 |